AFP and hepatocellular carcinoma: ROC curve was constructed to evaluate the performance of HIST1H3G. Additionally, AFP and PIVKA-II, which are commonly employed as serum-based biomarkers for HCC screening in clinical practice, were evaluated to assess their diagnostic accuracy.